Skip to content

Analysis of the Characteristics of Gut and Skin Microbiota in Patients with Dengue Fever and Chikungunya Fever

Analysis of the Characteristics of Gut and Skin Microbiota in Patients with Dengue Fever and Chikungunya Fever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128108
Enrollment
Unknown
Registered
2026-07-14
Start date
2025-08-14
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue fever, Chikungunya fever

Interventions

chikungunya:None
Dengue:None
health control:None

Sponsors

The People's Hospital of Baiyun District Guangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary signing of an informed consent form; 2. Aged between 25 and 65 years, regardless of gender; 3. Participants diagnosed with dengue fever or chikungunya fever based on a comprehensive assessment of their epidemiological evidence, clinical presentation and laboratory test results; a matched group of healthy individuals with no fever and no history of viral exposure will be enrolled at the same time.

Exclusion criteria

Exclusion criteria: 1. Use of antibiotics, antifungals or probiotics within 3 months prior to enrolment; 2. Chronic gastrointestinal disorders (such as inflammatory bowel disease, irritable bowel syndrome, chronic diarrhoea or constipation); 3. Concurrent acute infections (such as bacterial dysentery or COVID-19), or confirmed complications (such as dengue shock syndrome or neuropathy caused by chikungunya fever); 4. Patients in specific physiological conditions (pregnant or breastfeeding women, or patients who have undergone gastrointestinal surgery within the past 3 months).

Design outcomes

Primary

MeasureTime frame
Analysis of feces and skin microbiota;

Secondary

MeasureTime frame
Record clinical symptoms including peak temperature, time to defervescence, length of hospital stay, time for rash resolution, and incidence of clinical symptoms (headache, arthralgia, myalgia, fever,;Routine admission blood tests (complete blood count, hypersensitive C-reactive protein, erythrocyte sedimentation rate, cytokines, coagulation, liver function, kidney function, etc.);

Countries

China

Contacts

Public ContactYaqiu Long

The People's Hospital of Baiyun District Guangzhou

longqiuxinxin@163.com+86 20 66230567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026